Collegium Pharmaceutical
COLL
Precision Drilling
PDS
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
APLS Apellis Pharmaceuticals
- 27.170
- +0.840+3.19%
Trading Feb 27 12:51 ET
3.38BMarket Cap-13.38P/E (TTM)
27.540High26.580Low623.13KVolume26.580Open26.330Pre Close16.97MTurnover0.75%Turnover RatioLossP/E (Static)124.39MShares66.00052wk High14.25P/B2.26BFloat Cap24.34052wk Low--Dividend TTM83.08MShs Float94.750Historical High--Div YieldTTM3.65%Amplitude11.450Historical Low27.232Avg Price1Lot Size
About Apellis Pharmaceuticals Company
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.
Company Profile
SymbolAPLS
Company NameApellis Pharmaceuticals
Listing DateNov 9, 2017
Issue Price14.00
Founded2009
CEODr. Cedric Francois, M.D.
MarketNASDAQ
Employees706
Fiscal Year Ends12-31
Address100 5th Avenue
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451-8703
Phone1-617-977-5700
Websitehttp://www.apellis.com
Company Executives
- Name
- Position
- Salary
- Dr. Cedric Francois, M.D.
- Director, Chief Executive Officer and President
- 10.37M
- Nur Nicholson
- Chief Technical Operations Officer
- --
- Timothy E. Sullivan
- Chief Financial Officer and Treasurer
- 3.74M
- Dr. Jeffrey Eisele, PhD
- Chief Development Officer
- --
- Mark Jeffrey DeLong
- Chief Business and Strategy Officer
- --
- James George Chopas
- Vice President, Corporate Controller and Chief Accounting Officer
- --
- Pascal Deschatelets, PhD
- Chief Scientific Officer
- --
- Dr. Caroline Baumal, M.D.
- Chief Medical Officer
- 4.43M
- Karen Lewis
- Chief People Officer
- --
- David Acheson
- Executive Vice President, Commercial
- --
- Dr. Gerald L. Chan, Sc.D.
- Chairman of the Board
- 504.08K
- Stephanie Monaghan O’Brien
- Independent Director
- 488.46K
- A. Sinclair Dunlop
- Independent Director
- 480.96K
- Paul Fonteyne, M.S.
- Independent Director
- 489.08K
- Alec Machiels
- Independent Director
- 495.96K
- Keli Walbert
- Independent Director
- --
- David Watson
- General Counsel
- 4.89M
